The forecasted share of corresponding/leading authors in scientific publications in endocrinology, diabetes, and metabolism in the US is gradually decreasing from 2024 to 2028, suggesting a slight but consistent year-on-year decline. In 2023, the value stood at 92.79 indicating a decrease trend from 2024 onwards. Year-on-year percentage variations show marginal declines: -0.14% in 2025, -0.13% in 2026, -0.13% in 2027, and -0.11% in 2028. The compound annual growth rate (CAGR) over the five years suggests a slight but steady annual decrease.

Future trends to watch include:

Increased collaboration across institutions potentially influencing authorship trends.
Technological advancements may alter the dynamics of scientific writing and attribution.
Shifts in funding policies that may impact researchers' roles in projects.